With the cost of launching a new drug now over US $1 Billion, it is critical to set the right expectations for launch. The key to quantifying the opportunity is to identify and apply the right analogues.
IMS Analogue Planner is a unique strategic forecasting tool that selects historic analogues based on product attributes and market characteristics.
This interactive software and database tool contains a rich pool of potential benchmarks for a product. A user-friendly interface allows you to select the parameters for those criteria most likely to influence new product penetration. Your selections determine the most suitable benchmarking information for your product.
COUNTRY COVERAGE
IMS Analogue Planner covers the Hospital and Retail markets across the world’s Top 8 countries, with coverage increasing to cover China from 2008.
- EMEA: France, Germany, Italy, Spain, & UK
- North America: USA, & Canada
- Asia-Pacific: Japan and China (new from 2008)
